Citation tools
"Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3–Related Dwarfism." Journal of Pharmacology and Experimental Therapeutics
353.1
(2015):
132-149.
Web. 28 Dec. 2024.